Maria O Valenzuela-Almada

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Jeffrey A. Sparks, Zachary S. Wallace, Andrea M. Seet et al. · Annals of the Rheumatic Diseases · 2021 · 241 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Zara Izadi, Erica J. Brenner, Satveer K. Mahil et al. · JAMA Network Open · 2021 · 116 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance

Manuel F. Ugarte‐Gil, Graciela S. Alarcón, Zara Izadi et al. · Annals of the Rheumatic Diseases · 2022 · 92 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +14

Incidence, Prevalence, and Mortality of Lupus Nephritis: A <scp>Population‐Based</scp> Study Over Four Decades Using the Lupus Midwest Network

Mehmet Hocaoǧlu, Maria O Valenzuela-Almada, Jesse Y. Dabit et al. · Arthritis & Rheumatology · 2022 · 72 citations · Full text

Medicine, Nephrology, Clinical Epidemiology +9

Rising incidence and prevalence of systemic lupus erythematosus: a population-based study over four decades

Alí Duarte‐García, Mehmet Hocaoǧlu, Maria O Valenzuela-Almada et al. · Annals of the Rheumatic Diseases · 2022 · 68 citations · Full text

Veterinary Medicine, Health Sciences, Autoimmunity +16